ArticleActa neuropathologica2017

Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism.

Julien Chapuis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.